Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway

Conclusion: GLP-1RA exenatide can inhibit human VSMCs calcification through NF-κB/RANKL signaling.
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Source Type: research